🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Hims & Hers stock falls as Amazon launches Telehealth offering

Published 11/14/2024, 11:38 PM
© Reuters.
AMZN
-
HIMS
-

Investing.com -- Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns, which could pose significant competition for Hims & Hers’ subscription-based health services.

Amazon (NASDAQ:AMZN) said its new telehealth services, available to Prime members, cover men’s hair loss, eyelash growth, anti-aging skincare, ED, and motion sickness, all with upfront pricing.

Amazon touts the service as offering convenience and affordability, with rates as low as $16 per month for hair loss treatments.

Bergen Penhart, general manager for Amazon One Medical (TASE:PMCN) Pay-per-visit, highlighted Amazon’s commitment to accessible, affordable health care, saying the new service allows Prime members “to get expert clinical advice and prescribed treatments for common health, beauty, and lifestyle needs, all from the comfort of home.”

Amazon’s telehealth visits are available 24/7, allowing users to consult with clinicians for $29 through messaging and $49 via video. Once diagnosed, Prime members can have prescriptions filled through Amazon Pharmacy, which offers free delivery directly to their door, often the same day in select cities.

In response to the announcement, the stock of Hims & Hers—a company specializing in telehealth and subscription-based wellness products—plunged as investors weighed the impact of Amazon’s pricing and distribution capabilities on Hims & Hers’ market share.

As Amazon aggressively moves into this space, analysts anticipate potential market disruption for existing telehealth services.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.